Methyl N-[(1S)-1-[[(2S)-2-[6-[6-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]naphthalen-2-yl]-1H-imidazo[4,5-b]pyridin-2-yl]pyrrolidine-1-carbonyl]amino]-2-methylpropyl]carbamate
C41H50N10O6 — CID 155519411
Data last refreshed: (MolForge compound catalog, from PubChem)
About Methyl N-[(1S)-1-[[(2S)-2-[6-[6-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]naphthalen-2-yl]-1H-imidazo[4,5-b]pyridin-2-yl]pyrrolidine-1-carbonyl]amino]-2-methylpropyl]carbamate
Methyl N-[(1S)-1-[[(2S)-2-[6-[6-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]naphthalen-2-yl]-1H-imidazo[4,5-b]pyridin-2-yl]pyrrolidine-1-carbonyl]amino]-2-methylpropyl]carbamate (PubChem CID 155519411) has the molecular formula C41H50N10O6 and a molecular weight of 778.92 g/mol. Its IUPAC name is methyl N-[(1S)-1-[[(2S)-2-[6-[6-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]naphthalen-2-yl]-1H-imidazo[4,5-b]pyridin-2-yl]pyrrolidine-1-carbonyl]amino]-2-methylpropyl]carbamate.
Molecular Properties
| Compound Name | Methyl N-[(1S)-1-[[(2S)-2-[6-[6-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]naphthalen-2-yl]-1H-imidazo[4,5-b]pyridin-2-yl]pyrrolidine-1-carbonyl]amino]-2-methylpropyl]carbamate |
|---|---|
| PubChem CID | 155519411 |
| Molecular Formula | C41H50N10O6 |
| Molecular Weight | 778.92 g/mol |
| Exact Mass | 778.39 |
| IUPAC Name | methyl N-[(1S)-1-[[(2S)-2-[6-[6-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]naphthalen-2-yl]-1H-imidazo[4,5-b]pyridin-2-yl]pyrrolidine-1-carbonyl]amino]-2-methylpropyl]carbamate |
| SMILES | COC(=O)N[C@H](NC(=O)N1CCC[C@H]1c1nc2ncc(-c3ccc4cc(-c5cnc([C@@H]6CCCN6C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]5)ccc4c3)cc2[nH]1)C(C)C |
| InChI | InChI=1S/C41H50N10O6/c1-22(2)33(46-40(54)56-5)38(52)50-15-7-9-31(50)36-43-21-30(45-36)27-14-13-24-17-26(12-11-25(24)18-27)28-19-29-35(42-20-28)47-37(44-29)32-10-8-16-51(32)39(53)48-34(23(3)4)49-41(55)57-6/h11-14,17-23,31-34H,7-10,15-16H2,1-6H3,(H,43,45)(H,46,54)(H,48,53)(H,49,55)(H,42,44,47)/t31-,32-,33-,34-/m0/s1 |
| InChIKey | VSNRBBSPPQSRAL-CUPIEXAXSA-N |
| XLogP | 6.40 |
| TPSA | 199.56 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 57 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 778.92 |
| LogP ≤ 5 | 6.40 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 9 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'het-C-het_not_in_ring', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155519411 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.